DIA Biosimilars 2013

Cystic Fibrosis Foundation

CFFT, Pfizer expand collaboration on cystic fibrosis by $58M

Monday, November 19, 2012 02:46 PM

Cystic Fibrosis Foundation Therapeutics (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, has expanded its research collaboration with Pfizer designed to discover new drugs to treat people with the most common mutation of cystic fibrosis (CF), Delta F508.

More... »

Cenduit: Now with Patient Reminders

Genzyme, Cystic Fibrosis Foundation Therapeutics ink research agreement

Wednesday, November 16, 2011 02:33 PM

Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics, the nonprofit affiliate of the Cystic Fibrosis Foundation, have signed a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.

More... »

CRF Health – eCOA Forum

Bill Aims to Increase Enrollment for Rare-Disease Clinical Trials

Tuesday, June 23, 2009 08:47 AM

A new bill introduced in the House of Representatives last week seeks to increase patient participation in clinical trials for rare diseases.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs